Boston Scientific Corporation vs OneSpan Inc — how do they compare? Boston Scientific Corporation trades at $51.15 (market cap $74.19B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: Boston Scientific Corporation is far larger — about 123.5× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | OSPN | |
|---|---|---|
Market Cap | $74.19B | $600.69M |
Sector | Health | Technology |
52-Week High | $108.14 | $16.78 |
52-Week Low | $42.63 | $10.15 |
Enterprise Value | $86.27B | $569.77M |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →